NEW YORK, Sept. 6 — Nanogen (Nasdaq: NGEN), a maker of electronic-based genomic research devices, said Wednesday it had promoted its chief financial officer to the position of president.

Kieran Gallahue will retain the CFO title until a replacement is named, the company said.

Gallahue served as Nanogen's senior vice president and chief financial officer since July 1999 and as vice president of strategic marketing from January 1998 to July 1999.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.